Table 4 Partial correlation analysis between structural measures and clinical measures, where bold indicates significant results.
AGA | PGA | Swollen | Tender | Pain | EMS | HAQ | ESR | DAS28 | |
---|---|---|---|---|---|---|---|---|---|
Women | |||||||||
DXR‐BMD | |||||||||
r | −0.057 | −0.017 | −0.106 | −0.061 | −0.033 | −0.029 | −0.218 | +0.073 | −0.126 |
p Value | 0.495 | 0.840 | 0.197 | 0.457 | 0.694 | 0.763 | 0.008 | 0.460 | 0.201 |
DXR‐MCI | |||||||||
r | −0.031 | +0.002 | −0.051 | −0.002 | −0.028 | −0.047 | −0.170 | +0.048 | −0.064 |
p Value | 0.712 | 0.982 | 0.536 | 0.981 | 0.732 | 0.628 | 0.039 | 0.626 | 0.515 |
DXR‐CT | |||||||||
r | −0.040 | −0.005 | −0.088 | −0.035 | −0.025 | −0.021 | −0.193 | +0.072 | −0.095 |
p Value | 0.629 | 0.951 | 0.286 | 0.668 | 0.766 | 0.827 | 0.018 | 0.464 | 0.333 |
Sharp score | |||||||||
r | +0.212 | +0.143 | +0.170 | +0.190 | +0.166 | −0.050 | +0.298 | +0.100 | +0.246 |
p Value | 0.010 | 0.083 | 0.038 | 0.020 | 0.043 | 0.607 | <0.005 | 0.311 | 0.011 |
Men | |||||||||
DXR‐BMD | −0.292 | −0.296 | +0.000 | −0.214 | −0.277 | −0.215 | −0.348 | −0.024 | −0.167 |
r | 0.030 | 0.030 | 0.999 | 0.116 | 0.041 | 0.162 | 0.009 | 0.880 | 0.290 |
p Value | |||||||||
DXR‐MCI | |||||||||
r | −0.211 | −0.150 | +0.109 | −0.038 | −0.223 | −0.246 | −0.265 | −0.039 | −0.045 |
p Value | 0.121 | 0.279 | 0.428 | 0.782 | 0.102 | 0.108 | 0.051 | 0.806 | 0.776 |
DXR‐CT | |||||||||
r | −0.272 | −0.266 | +0.045 | −0.163 | −0.254 | −0.238 | −0.332 | −0.038 | −0.145 |
0.044 | 0.052 | 0.747 | 0.235 | 0.061 | 0.119 | 0.013 | 0.811 | 0.361 | |
Sharp score | |||||||||
r | +0.242 | +0.229 | +0.225 | +0.175 | +0.176 | +0.020 | +0.261 | +0.186 | +0.233 |
p Value | 0.076 | 0.096 | 0.099 | 0.201 | 0.199 | 0.554 | 0.054 | 0.239 | 0.138 |
Age at x ray and weight were used as controlling variables.